Search filters

List of works by Tina Vilsbøll

A 25-year-old woman with type 2 diabetes and liver disease

scientific article

A Fixed Ratio Combination of Insulin Degludec and Liraglutide (IDegLira) Reduces Glycemic Fluctuation and Brings More Patients with Type 2 Diabetes Within Blood Glucose Target Ranges

scientific article

A decision support tool for appropriate glucose-lowering therapy in patients with type 2 diabetes

scientific article

A sandwich ELISA for measurement of the primary glucagon-like peptide-1 metabolite

scientific article published on 18 April 2017

Adverse drug reactions associated with the use of liraglutide in patients with type 2 diabetes--focus on pancreatitis and pancreas cancer

scientific article

Alcohol consumption among patients with diabetes: a survey-based cross-sectional study of Danish adults with diabetes

scientific article

Benefits and Harms of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis

scientific article

Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects

scientific article published in July 2003

Cardiovascular biomarkers in clinical studies of type 2 diabetes

scientific article

Cardiovascular safety and benefits of GLP-1 receptor agonists

scientific article published on 19 January 2017

Cephalic phase secretion of insulin and other enteropancreatic hormones in humans

scientific article published on 22 October 2015

Characterisation of oral and i.v. glucose handling in truncally vagotomised subjects with pyloroplasty

scientific article published on 6 July 2013

Cholecystokinin-Induced Gallbladder Emptying and Metformin Elicit Additive Glucagon-Like Peptide-1 Responses

scientific article published on 22 March 2016

Cholesterol remnants and triglycerides are associated with decreased myocardial function in patients with type 2 diabetes

scientific article published on 22 September 2016

Circulating Glucagon 1-61 Regulates Blood Glucose by Increasing Insulin Secretion and Hepatic Glucose Production

scientific article published in November 2017

Clinical Considerations When Initiating and Titrating Insulin Degludec/Liraglutide (IDegLira) in People with Type 2 Diabetes

scientific article published on 01 February 2020

Contribution of liraglutide in the fixed-ratio combination of insulin degludec and liraglutide (IDegLira).

scientific article published on 11 August 2014

Cross-sectoral collaboration in type 2 diabetes management in Denmark ⬇️

scientific article published in January 2018

Dapagliflozin Plus Saxagliptin Add-on Therapy Compared With Insulin in Patients With Type 2 Diabetes Poorly Controlled by Metformin With or Without Sulfonylurea Therapy: A Randomized Clinical Trial

scientific article published on 04 June 2019

Determinants of Fasting Hyperglucagonemia in Patients with Type 2 Diabetes and Nondiabetic Control Subjects

scientific article published on 16 October 2018

Dialysis-Requiring Acute Kidney Injury in Denmark 2000-2012: Time Trends of Incidence and Prevalence of Risk Factors-A Nationwide Study

scientific article published on 10 February 2016

Does a GLP-1 receptor agonist change glucose tolerance in patients treated with antipsychotic medications? Design of a randomised, double-blinded, placebo-controlled clinical trial

scientific article published on 25 March 2014

Does glucagon-like peptide-1 (GLP-1) receptor agonist stimulation reduce alcohol intake in patients with alcohol dependence: study protocol of a randomised, double-blinded, placebo-controlled clinical trial

EFFICACY AND SAFETY OF IDEGLIRA IN OLDER PATIENTS WITH TYPE 2 DIABETES

scientific article published on 01 November 2018

Effect of Antibiotics on Gut Microbiota, Gut Hormones and Glucose Metabolism

scientific article published on 12 November 2015

Effect of Oxyntomodulin, Glucagon, GLP-1, and Combined Glucagon +GLP-1 Infusion on Food Intake, Appetite, and Resting Energy Expenditure

scientific article published on 7 October 2015

Effect of Roux-en-Y gastric bypass on the distribution and hormone expression of small-intestinal enteroendocrine cells in obese patients with type 2 diabetes

scientific article

Effect of bile acid sequestrants on glycaemic control: protocol for a systematic review with meta-analysis of randomised controlled trials

scientific article

Effect of exercise combined with glucagon-like peptide-1 receptor agonist treatment on cardiac function: A randomized double-blind placebo-controlled clinical trial

scientific article published on 11 February 2017

Effect of the EndoBarrier Gastrointestinal Liner on obesity and type 2 diabetes: protocol for systematic review and meta-analysis of clinical studies

scientific article

Effects of combined GIP and GLP-1 infusion on energy intake, appetite and energy expenditure in overweight/obese individuals: a randomised, crossover study

scientific article published on 25 January 2019

Effects of glucagon-like peptide-1 on glucagon secretion in patients with non-alcoholic fatty liver disease

scientific article published on 25 November 2015

Effects of glucagon-like peptide-1 receptor agonists on cardiovascular risk factors: A narrative review of head-to-head comparisons

scientific article published on 12 October 2017

Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials

scientific article

Efficacy and Safety of Glimepiride With or Without Linagliptin Treatment in Patients With HNF1A Diabetes (Maturity-Onset Diabetes of the Young Type 3): A Randomized, Double-Blinded, Placebo-Controlled, Crossover Trial (GLIMLINA)

scientific article published on 13 July 2020

Efficacy and safety of dapagliflozin plus saxagliptin versus insulin glargine over 52 weeks as add-on to metformin with or without sulphonylurea in patients with type 2 diabetes: A randomized, parallel-design, open-label, Phase 3 trial

scientific article published on 31 January 2020

Efficacy and safety of fixed-ratio combination of insulin degludec and liraglutide (IDegLira) for the treatment of type 2 diabetes

scientific article published on 2 February 2017

Emerging GLP-1 receptor agonists

scientific article published on 09 September 2011

Enteroendocrine K and L cells in healthy and type 2 diabetic individuals

scientific article published on 28 September 2017

Evidence of Extrapancreatic Glucagon Secretion in Man

article

Exenatide: pharmacokinetics, clinical use, and future directions

scientific article published on 13 January 2017

Fixed combination of insulin and a glucagon-like peptide-1 analog for the treatment of type 2 diabetes, exemplified by insulin degludec and liraglutide

scientific article published on 30 March 2015

Fixed-ratio combination of insulin degludec and liraglutide (IDegLira) improves cardiovascular risk markers in patients with type 2 diabetes uncontrolled on basal insulin

scientific article published on 08 April 2019

GIP's effect on bone metabolism is reduced by the selective GIP receptor antagonist GIP(3-30)NH2

scientific article published on 14 October 2019

GIP(3-30)NH2 is an efficacious GIP receptor antagonist in humans: a randomised, double-blinded, placebo-controlled, crossover study

scientific article

Gastric aspiration therapy is a possible alternative to treatment of obesity ⬇️

scientific article published in August 2017

Glucagon-like peptide 1 in health and disease

scientific article published on 01 July 2018

Glucagon-like peptide-1 receptor agonists and risk of acute pancreatitis in patients with type 2 diabetes

scientific article published on 20 January 2017

Glucagon-like peptide-1, glucose homeostasis and diabetes

scientific article published on 18 March 2008

Glucagon-like peptide-2, but not glucose-dependent insulinotropic polypeptide, stimulates glucagon release in patients with type 1 diabetes

scientific article published on 24 May 2010

Gluco-metabolic effects of oral and intravenous alcohol administration in men

scientific article published on 01 October 2019

Glucose metabolism in patients with psoriasis

scientific article published on 13 December 2018

Glucose-Dependent Insulinotropic Polypeptide (GIP) Inhibits Bone Resorption Independently of Insulin and Glycemia

Glucose-Dependent Insulinotropic Polypeptide (GIP) Reduces Bone Resorption in Patients With Type 2 Diabetes

scientific article published on 16 July 2020

Glucose-Dependent Insulinotropic Polypeptide Is a Pancreatic Polypeptide Secretagogue in Humans

scientific article published on 01 March 2020

Glucose-dependent insulinotropic polypeptide augments glucagon responses to hypoglycemia in type 1 diabetes

scientific article published on 22 July 2014

Glucose-dependent insulinotropic polypeptide inhibits bone resorption in humans

scientific article

Glucose-dependent insulinotropic polypeptide: a bifunctional glucose-dependent regulator of glucagon and insulin secretion in humans

scientific article

Glucose-dependent insulinotropic polypeptide: blood glucose stabilizing effects in patients with type 2 diabetes

scientific article published on 11 December 2013

Glucose-lowering effects and low risk of hypoglycemia in patients with maturity-onset diabetes of the young when treated with a GLP-1 receptor agonist: a double-blind, randomized, crossover trial

scientific article published in July 2014

Glucose-lowering effects and mechanisms of the bile acid-sequestering resin sevelamer

scientific article published in March 2018

Guanylin and uroguanylin mRNA expression is increased following Roux-en-Y gastric bypass, but guanylins do not play a significant role in body weight regulation and glycemic control

scientific article published on 28 December 2017

Gut Mucosal Gene Expression and Metabolic Changes After Roux-en-Y Gastric Bypass Surgery

scientific article published on 01 November 2020

Hyperglucagonaemia analysed by glucagon sandwich ELISA: nonspecific interference or truly elevated levels?

scientific article published on 03 June 2014

Hyperglucagonemia correlates with plasma levels of non-branched-chain amino acids in patients with liver disease independent of type 2 diabetes

scientific article published on 28 September 2017

IDegLira Versus Alternative Intensification Strategies in Patients with Type 2 Diabetes Inadequately Controlled on Basal Insulin Therapy

scientific article

Impact of type 2 diabetes and duration of type 2 diabetes on cardiac structure and function

scientific article published on 5 July 2016

Impaired incretin-induced amplification of insulin secretion after glucose homeostatic dysregulation in healthy subjects

scientific article published on 8 February 2012

Impaired regulation of the incretin effect in patients with type 2 diabetes

scientific article published on 20 January 2011

Inappropriate glucagon response after oral compared with isoglycemic intravenous glucose administration in patients with type 1 diabetes

scientific article published on 26 January 2010

Increased expression of glucagon-like peptide-1 receptors in psoriasis plaques

scientific article published in February 2013

Increased postprandial GIP and glucagon responses, but unaltered GLP-1 response after intervention with steroid hormone, relative physical inactivity, and high-calorie diet in healthy subjects

scientific article published on 3 November 2010

Increased postprandial responses of GLP-1 and GIP in patients with chronic pancreatitis and steatorrhea following pancreatic enzyme substitution

article

Incretin effect and glucagon responses to oral and intravenous glucose in patients with maturity-onset diabetes of the young--type 2 and type 3.

scientific article

Incretin mimetics: a novel therapeutic option for patients with type 2 diabetes - a review

scientific article

Incretin-based therapies: viewpoints on the way to consensus

scientific article

Incretin-based therapy of type 2 diabetes mellitus

scientific article published on February 2009

Influence of gastrointestinal factors on glucose metabolism in patients with cirrhosis

scientific article published on 13 April 2015

Is glucagon-like peptide-1 fully protected by the dipeptidyl peptidase 4 inhibitor sitagliptin when administered to patients with type 2 diabetes?

scientific article published on 09 May 2018

Is the current therapeutic armamentarium in diabetes enough to control the epidemic and its consequences? What are the current shortcomings?

scientific article published on 20 June 2009

Liraglutide for the Treatment of Antipsychotic Drug-Induced Weight Gain-Reply

scientific article published on 27 September 2017

Liraglutide, a long-acting human glucagon-like peptide-1 analog, given as monotherapy significantly improves glycemic control and lowers body weight without risk of hypoglycemia in patients with type 2 diabetes

scientific article

Liraglutide: a once-daily GLP-1 analogue for the treatment of type 2 diabetes mellitus

scientific article published on February 2007

Lixisenatide for type 2 diabetes mellitus

scientific article published on 11 March 2011

Long-acting GLP-1 analogs for the treatment of type 2 diabetes mellitus

scientific article published on January 2008

Loss of incretin effect is a specific, important, and early characteristic of type 2 diabetes

scientific article published on May 2011

Mathematical Modelling of Glucose-Dependent Insulinotropic Polypeptide and Glucagon-like Peptide-1 following Ingestion of Glucose

scientific article published on 4 April 2017

Mechanisms of the incretin effect in subjects with normal glucose tolerance and patients with type 2 diabetes

scientific article

Metformin is a possible glucagon-like peptide 1 stimulator ⬇️

scientific article published in March 2018

Metformin-associated risk of acute dialysis in patients with type 2 diabetes: A nationwide cohort study

scientific article published on 18 August 2016

Metformin-induced glucagon-like peptide-1 secretion contributes to the actions of metformin in type 2 diabetes

scientific article published on 06 December 2018

Neuroprotective Mechanisms of Glucagon-like Peptide-1-based Therapies in Ischaemic Stroke: A Systematic Review based on Pre-Clinical Studies

scientific article published on 7 February 2018

No Acute Effects of Exogenous Glucose-Dependent Insulinotropic Polypeptide on Energy Intake, Appetite, or Energy Expenditure When Added to Treatment With a Long-Acting Glucagon-Like Peptide 1 Receptor Agonist in Men With Type 2 Diabetes

scientific article published on 16 January 2020

No changes in levels of bone formation and resorption markers following a broad-spectrum antibiotic course

scientific article published on 04 September 2018

No hypoglycemia after subcutaneous administration of glucagon-like peptide-1 in lean type 2 diabetic patients and in patients with diabetes secondary to chronic pancreatitis

scientific article published in September 2003

Nonalcoholic Fatty Liver Disease Is Prevalent in Women With Prior Gestational Diabetes Mellitus and Independently Associated With Insulin Resistance and Waist Circumference

scientific article

Normal secretion and action of the gut incretin hormones glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in young men with low birth weight

scientific article published on 17 May 2005

Normal secretion of the incretin hormones glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 during gestational diabetes mellitus

scientific article published in January 2007

On the role of gallbladder emptying and incretin hormones for nutrient-mediated TSH suppression in patients with type 2 diabetes

scientific article

One Year's Treatment with the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide Decreases Hepatic Fat Content in Women with Nonalcoholic Fatty Liver Disease and Prior Gestational Diabetes Mellitus in a Randomized, Placebo-Controlled Trial

scientific article published on 06 October 2020

Oxyntomodulin Identified as a Marker of Type 2 Diabetes and Gastric Bypass Surgery by Mass-spectrometry Based Profiling of Human Plasma

scientific article published on 31 March 2016

Pancreatic polypeptide responses to isoglycemic oral and intravenous glucose in humans with and without intact vagal innervation

scientific article published on 26 July 2015

Patient preferences for diabetes management among people with type 2 diabetes in Denmark - a discrete choice experiment

scientific article published on 10 October 2011

Patients with psoriasis are insulin resistant

scientific article published in February 2015

Perceptions of diabetes control among people with type 2 diabetes treated with basal insulin in Sweden, Switzerland, and the United Kingdom

scientific article

Perceptions of diabetes control among physicians and people with type 2 diabetes uncontrolled on basal insulin in Sweden, Switzerland, and the United Kingdom

scientific article published on 5 February 2016

Plasma dipeptidyl peptidase-IV activity in patients with type-2 diabetes mellitus correlates positively with HbAlc levels, but is not acutely affected by food intake

scientific article published in September 2006

Postprandial Plasma Concentrations of Individual Bile Acids and FGF-19 in Patients With Type 2 Diabetes

scientific article published on 7 June 2016

Postprandial gallbladder emptying in patients with type 2 diabetes: potential implications for bile-induced secretion of glucagon-like peptide 1.

scientific article published on July 2014

Postprandial gut hormone responses and glucose metabolism in cholecystectomized patients

scientific article published on 28 December 2012

Postprandial incretin and islet hormone responses and dipeptidyl-peptidase 4 enzymatic activity in patients with maturity onset diabetes of the young

scientific article published on 7 May 2015

Presence of micro- and macroalbuminuria and the association with cardiac mechanics in patients with type 2 diabetes

scientific article published on 3 October 2017

Preserved inhibitory potency of GLP-1 on glucagon secretion in type 2 diabetes mellitus

scientific article published on 16 October 2009

Protocol for Meal-time Administration of Exenatide for Glycaemic Control in Type 1 Diabetes Cases (The MAG1C trial): a randomised, double-blinded, placebo-controlled trial.

scientific article published on 27 June 2018

Reduced Incretin Effect in Type 2 Diabetes

article by Filip K. Knop et al published 18 May 2007 in Diabetes

Risk stratification by endocrinologists of patients with type 2 diabetes in a Danish specialised outpatient clinic: a cross-sectional study

scientific article

Role of gastrointestinal hormones in postprandial reduction of bone resorption

scientific article published in December 2003

Secretion of glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes: systematic review and meta-analysis of clinical studies

scientific article

Semaglutide (SUSTAIN and PIONEER) reduces cardiovascular events in type 2 diabetes across varying cardiovascular risk

scientific article published on 05 February 2020

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

scientific article

Semaglutide improves health-related quality of life vs placebo when added to standard of care in patients with type 2 diabetes at high cardiovascular risk (SUSTAIN 6)

scientific article published on 30 March 2020

Semaglutide, reduction in glycated haemoglobin and the risk of diabetic retinopathy

scientific article published on 27 November 2017

Separate and Combined Effects of GIP and GLP-1 Infusions on Bone Metabolism in Overweight Men without Diabetes

scientific article published on 01 July 2019

Separate and Combined Glucometabolic Effects of Endogenous Glucose-Dependent Insulinotropic Polypeptide and Glucagon-like Peptide 1 in Healthy Individuals

scientific article published on 09 January 2019

Single-Dose Metformin Enhances Bile Acid-Induced Glucagon-Like Peptide-1 Secretion in Patients With Type 2 Diabetes

scientific article published on 18 August 2017

Specificity and sensitivity of commercially available assays for glucagon and oxyntomodulin measurement in humans

scientific article published on 8 March 2014

Sustained weight loss after treatment with a glucagon-like peptide-1 receptor agonist in an obese patient with schizophrenia and type 2 diabetes

scientific article

The GLP-1 receptor agonist lixisenatide reduces postprandial glucose in patients with diabetes secondary to total pancreatectomy: a randomised, placebo-controlled, double-blinded crossover trial

scientific article published on 11 May 2020

The Role of Glucagon in the Pathophysiology and Treatment of Type 2 Diabetes

scientific article

The bile acid-sequestering resin sevelamer eliminates the acute GLP-1 stimulatory effect of endogenously released bile acids in patients with type 2 diabetes

scientific article published on 8 August 2017

The effect of a glucagon-like peptide-1 receptor agonist on glucose tolerance in women with previous gestational diabetes mellitus: protocol for an investigator-initiated, randomised, placebo-controlled, double-blinded, parallel intervention trial

scientific article

The effect of empagliflozin on oxidative nucleic acid modifications in patients with type 2 diabetes: protocol for a randomised, double-blinded, placebo-controlled trial

scientific article published on 09 May 2017

The effect of exogenous GLP-1 on food intake is lost in male truncally vagotomized subjects with pyloroplasty

scientific article published on 18 April 2013

The effect of glucagon-like peptide 1 on cardiovascular risk

scientific article published on 31 January 2012

The effects of sodium-glucose co-transporter 2 inhibitors in patients with type 2 diabetes: protocol for a systematic review with meta-analysis of randomised trials

scientific article

The elimination rates of intact GIP as well as its primary metabolite, GIP 3-42, are similar in type 2 diabetic patients and healthy subjects

scientific article published on 28 August 2006

The glucagonostatic and insulinotropic effects of glucagon-like peptide 1 contribute equally to its glucose-lowering action

scientific article

The impact of EndoBarrier gastrointestinal liner in obese patients with normal glucose tolerance and in patients with type 2 diabetes

scientific article published on 3 October 2016

The incretin system and its role in type 2 diabetes mellitus

scientific article published on 20 August 2008

The insulinotropic effect of GIP is impaired in patients with chronic pancreatitis and secondary diabetes mellitus as compared to patients with chronic pancreatitis and normal glucose tolerance

scientific article published on 13 July 2007

The role of efferent cholinergic transmission for the insulinotropic and glucagonostatic effects of GLP-1.

scientific article published in July 2015

The separate and combined impact of the intestinal hormones, GIP, GLP-1, and GLP-2, on glucagon secretion in type 2 diabetes

scientific article published on 8 March 2011

The spectrum of antidiabetic actions of GLP-1 in patients with diabetes

scientific article published on August 2009

The use of double-balloon enteroscopy in retrieving mucosal biopsies from the entire human gastrointestinal tract

scientific article

Therapy: Liraglutide - preventing or postponing T2DM diagnosis?

scientific article

Trends in One-Year Outcomes of Dialysis-Requiring Acute Kidney Injury in Denmark 2005-2012: A Population-Based Nationwide Study

scientific article

Type 2 Diabetes Patients Reach Target Glycemic Control Faster Using IDegLira than Either Insulin Degludec or Liraglutide Given Alone

scientific article published on 19 February 2016

Typical Danish Caucasian type 2 diabetic patients do not commonly carry genetic variants in GIP and GLP-1 encoding regions of the proGIP and proglucagon genes

scientific article

Unprecedented high insulin secretion in a healthy human subject after intravenous glucagon-like peptide-1: a case report

scientific article

Women with prior gestational diabetes mellitus and prediabetes are characterised by a decreased incretin effect

scientific article published on 31 March 2017

Paulina is supported by:

About Paulina

Help